Department of Pharmacotherapy, University of Utah

We are excited to share the U of U REDTalk "Healthcare Providers Ignoring Stop Signs - An Odyssey to Novel Drug-Drug Interaction Management" presented by our own, Dan Malone! His presentation highlights drug safety and the importance of reducing drug interactions. Check out his influential talk!

REDtalks Faculty Speaker Series: Daniel Malone “Healthcare Providers Ignoring Stop Signs—An Odyssey to Novel Drug-Drug Interaction Management” by Daniel Malone, RPh, Ph.D., FAMCP, College of Pharmacy

We are excited to announce the spring 2024 graduates from the Doctor of Philosophy in Pharmacotherapy Outcomes Research program!

Congratulations!
Madeline Brendle, PhD, MPH
Kendra Lawrence, PhD, MHLP
Sakil Syeed, PhD

We are excited to spotlight Ratthanon Prasitwarachot's experience in our PhD program. You can find additional information on our website and stay tuned for upcoming student spotlights!

https://lnkd.in/gVt6rTAc

Many current students and faculty are attending the 2023 ASHP Midyear Meeting in Anaheim, CA this week! We celebrate the accomplishments of the those presenting their work and enjoy the opportunity to connect with colleagues and alumni from around the nation.

Congratulations to Casey Tak, PhD, MPH for being selected as the 2024-25 ELEVATE Scholar! Casey's selection for this award is based in his project titled, "Experiences accessing and preferences of MOUD among pregnant and postpartum individuals with opioid use disorder."

Learn more about Casey on our department webpage: https://pharmacy.utah.edu/pharmacotherapy/faculty/tak

More information on the ELEVATE Center can be found here: https://healthcare.utah.edu/press-releases/2023/09/new-maternal-health-research-center-aims-reduce-pregnancy-related-deaths

We are excited about the impact our PhD students will have on health economics outcomes research. Learn more about Elvis Duru's experience on our website and stay tuned for upcoming student spotlights! https://pharmacy.utah.edu/pharmacotherapy/graduate-studies/phd-students

Our faculty member, Daniel C. Malone, Ph.D., was recently highlighted as an AHRQ Grantee in their recent newsletter. He is helping to make care safer by increasing understanding of drug-drug interactions and developing tools that alert physicians and patients to potentially risky drug combinations. Over the past 22 years his research has documented gaps in evidence and also provided solutions to address alert fatigue, a common problem with drug-drug interaction warnings.

Learn more from his profile here: https://www.ahrq.gov/funding/grantee-profiles/grtprofile-malone.html

Research conducted by our pharmacotherapy department has been highlighted in the recent September 2023 issue of PharmacyToday! Check out the article below highlighting the work published by our faculty members Nathorn Chaiyakunapruk, PharmD, PhD, Elizabeth Bald, PharmD, and Casey Tak, MPH, PhD along with previous post-doctoral fellows Alexandre H. Watanabe, PharmD and Sajesh K. Veettil, PhD.

Pharmacy-based herpes zoster vaccinations boost rates, are more cost-effective Jonathan Little, PharmD Health benefits of the herpes zoster vaccine are well-documented, but lesser known are the economic impacts of a community pharmacy–based herpes zoster vaccination service in the United States. According to findings of a research study published May 16, 2023, in JAPhA, 11,5...

Congratulations to Priyanka Ghule on receiving the Skaggs Graduate Research Fellowship Award for 2023-24! The award will support the continued pursuit of her PhD dissertation project titled "Evaluation of the effectiveness of the insulin co-pay cap legislation in patients with Type 2 Diabetes Mellitus".

"The price of insulin has been growing exorbitantly over the years and has increased by 110% from 2012-2017. To offset the rising insulin costs and the increasing prevalence of diabetes, many states in the United States implemented the insulin co-pay cap legislation, limiting out-of-pocket insulin costs, ranging from $30-$100 for a 30-day supply. Although this policy was implemented to benefit the patients, not all patients are eligible to reap the benefits of this policy due to various limitations. Therefore, this Ph.D. dissertation aims to evaluate the effectiveness of the co-pay cap legislation in patients with Type 2 Diabetes Mellitus (T2DM). The goal of this Ph.D. dissertation will be realized via three different studies, which will employ a combination of qualitative and quantitative methods. The findings of this study will help generate evidence-based insights that can inform various stakeholders like patients, providers, insurers, and policymakers regarding the effectiveness of the co-pay cap legislation. By evaluating the effectiveness of the co-pay cap legislation, this dissertation has the potential to contribute to future efforts toward equitable access to insulin and improved healthcare for T2DM patients." - Priyanka Ghule, MS

Big shout out to everyone that attended! The department had a blast heading into the 50's era with a soda bar, snacks and co****le during our PhD Student Happy Hour. 🥤🥤🥤

Nice Job!
Dr. Aaron Wilson and Dr. Aubrey Jones presenting their poster at the recent Anticoagulation Forum National Conference in San Francisco.